FLNA
Filana Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.68
−3.06%3
Insider buys (3m)
0
Insider sells (3m)
$356.3K
Net value (3m)
-32.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 1, 2026 | Barry Richard · director, officer: President & CEO | Purchase | 206,813 | $0.90 |
| Oct 1, 2026 | Barry Richard · director, officer: President & CEO | Purchase | 100,000 | $0.92 |
| Sep 30, 2026 | Barry Richard · director, officer: President & CEO | Purchase | 93,091 | $0.84 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 1, 2026